BioCentury | Nov 20, 2020
Product Development

COVID vaccine updates for Pfizer-BioNTech, CureVac and Sinovac; plus Disbrow becomes permanent BARDA director

...plans to start a pivotal trial of the candidate before year-end.Disbrow becomes permanent BARDA directorThe U.S. Biomedical Advanced Research and Development Authority...
BioCentury | Oct 15, 2020
Product Development

Oct. 14 Quick Takes: FDA approves first Ebola therapy; plus Vertex tumbles after hours on AAT discontinuation

...a control, in the PALM study. Under a July deal, Regeneron will deliver to the U.S. Biomedical Advanced Research and Development Authority...
BioCentury | Sep 11, 2020
Product Development

Governments must work alongside industry to fill the cracks exposed by COVID-19 before the next, inevitable, pandemic

...outbreak, believes government organizations such as the U.S. Biomedical Advanced Research and Development Authority...
BioCentury | Aug 6, 2020
Product Development

Warp Speed makes J&J COVID-19 vaccine program fifth above $1B

...#), tocilizumab (Generic), RoActemra (Informal), MRA (Informal), Actemra (Informal) Leukine, sargramostim (GZ402664, Granulocyte macrophage-colony stimulating factor (GM-CSF)) U.S. Biomedical Advanced Research and Development Authority U.S...
BioCentury | Jul 13, 2020
Politics, Policy & Law

Cipla’s withdrawal of antibiotic marketing application latest sign of AMR market failure

...investigation plan, made it commercially unviable. Achaogen Inc. raised more than $500 million from the U.S. Biomedical Advanced Research and Development Authority...
BioCentury | May 30, 2020
Product Development

Sorting out COVID-19 consortia

...Staff Writer AZD1222, ChAdOx1 nCov-19 (ChAdOx1) Bill & Melinda Gates Foundation FNIH NIH Rhythm Pharmaceuticals Inc. Wellcome Trust Novartis AG AstraZeneca plc University of Oxford BARDA U.S. Biomedical Advanced Research and Development Authority CDC U.S...
BioCentury | May 20, 2020
Product Development

BARDA takes steps to secure supply chain as more companies look to scale up manufacturing

...TLR9 - Toll-like receptor 9 Elizabeth S. Eaton, Staff Writer CpG 1018 ABX464 U.S. Department of Health and Human Services BARDA U.S. Biomedical Advanced Research and Development Authority Dynavax...
BioCentury | Apr 17, 2020
Product Development

Oxford adds to surge of pandemic deals, enlisting more manufacturers for COVID-19 vaccine

...place (see “As COVID-19 Vaccines Progress, Science and Policy Questions Become more Urgent” ). The U.S. Biomedical Advanced Research and Development Authority...
BioCentury | Apr 15, 2020
Deals

As COVID-19 vaccines progress, science and policy questions become more urgent

...considering creating new adjuvant manufacturing capacity in North America and Europe, including the U.K. The U.S. Biomedical Advanced Research and Development Authority...
BioCentury | Dec 17, 2018
Politics, Policy & Law

When drugs can’t go generic: Honoring our end of the contract with 'synthetic genericization'

...ALXN), Boston, Mass. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland U.S. Biomedical Advanced Research and Development Authority...
Items per page:
1 - 10 of 16
BioCentury | Nov 20, 2020
Product Development

COVID vaccine updates for Pfizer-BioNTech, CureVac and Sinovac; plus Disbrow becomes permanent BARDA director

...plans to start a pivotal trial of the candidate before year-end.Disbrow becomes permanent BARDA directorThe U.S. Biomedical Advanced Research and Development Authority...
BioCentury | Oct 15, 2020
Product Development

Oct. 14 Quick Takes: FDA approves first Ebola therapy; plus Vertex tumbles after hours on AAT discontinuation

...a control, in the PALM study. Under a July deal, Regeneron will deliver to the U.S. Biomedical Advanced Research and Development Authority...
BioCentury | Sep 11, 2020
Product Development

Governments must work alongside industry to fill the cracks exposed by COVID-19 before the next, inevitable, pandemic

...outbreak, believes government organizations such as the U.S. Biomedical Advanced Research and Development Authority...
BioCentury | Aug 6, 2020
Product Development

Warp Speed makes J&J COVID-19 vaccine program fifth above $1B

...#), tocilizumab (Generic), RoActemra (Informal), MRA (Informal), Actemra (Informal) Leukine, sargramostim (GZ402664, Granulocyte macrophage-colony stimulating factor (GM-CSF)) U.S. Biomedical Advanced Research and Development Authority U.S...
BioCentury | Jul 13, 2020
Politics, Policy & Law

Cipla’s withdrawal of antibiotic marketing application latest sign of AMR market failure

...investigation plan, made it commercially unviable. Achaogen Inc. raised more than $500 million from the U.S. Biomedical Advanced Research and Development Authority...
BioCentury | May 30, 2020
Product Development

Sorting out COVID-19 consortia

...Staff Writer AZD1222, ChAdOx1 nCov-19 (ChAdOx1) Bill & Melinda Gates Foundation FNIH NIH Rhythm Pharmaceuticals Inc. Wellcome Trust Novartis AG AstraZeneca plc University of Oxford BARDA U.S. Biomedical Advanced Research and Development Authority CDC U.S...
BioCentury | May 20, 2020
Product Development

BARDA takes steps to secure supply chain as more companies look to scale up manufacturing

...TLR9 - Toll-like receptor 9 Elizabeth S. Eaton, Staff Writer CpG 1018 ABX464 U.S. Department of Health and Human Services BARDA U.S. Biomedical Advanced Research and Development Authority Dynavax...
BioCentury | Apr 17, 2020
Product Development

Oxford adds to surge of pandemic deals, enlisting more manufacturers for COVID-19 vaccine

...place (see “As COVID-19 Vaccines Progress, Science and Policy Questions Become more Urgent” ). The U.S. Biomedical Advanced Research and Development Authority...
BioCentury | Apr 15, 2020
Deals

As COVID-19 vaccines progress, science and policy questions become more urgent

...considering creating new adjuvant manufacturing capacity in North America and Europe, including the U.K. The U.S. Biomedical Advanced Research and Development Authority...
BioCentury | Dec 17, 2018
Politics, Policy & Law

When drugs can’t go generic: Honoring our end of the contract with 'synthetic genericization'

...ALXN), Boston, Mass. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland U.S. Biomedical Advanced Research and Development Authority...
Items per page:
1 - 10 of 16